On Monday, in the course of current trade, Shares of Motorola Solutions Inc (NYSE:MSI), climbed 0.21%, and is now trading at $67.22.
Motorola Solutions, declared the final results of its modified “Dutch Auction” tender offer, which expired at midnight, Eastern Daylight time, at the end of the day on Thursday, Sept. 3, 2015.
Based on the final count by the depositary for the tender offer, Motorola Solutions accepted for payment an aggregate of 30,075,146 shares at a purchase price of $66.50 per share. Because the number of shares tendered at or below the $66.50 purchase price (or by shareholders electing to tender at the ultimate purchase price determined under the tender offer terms) exceeded the amount that Motorola Solutions offered to purchase, the resulting proration factor, after giving effect to the priority for “odd lots,” was about 95 percent. The depositary will promptly pay for all the shares accepted for purchase and will return all other shares tendered.
Motorola Solutions, Inc. provides mission-critical communication infrastructure, devices, software, and services in North America, Latin America, the Asia Pacific, the Middle East, Europe, and Africa. The company operates in two segments, Products and Services. The Products segment offers a portfolio of network infrastructure, devices, accessories, and software for government, public safety and first-responder agencies, municipalities, and commercial and industrial customers.
During an Afternoon trade, Shares of Albemarle Corporation (NYSE:ALB), climbed 1.44%, and is now trading at $46.36.
Albemarle Corporation, declared its intention to add up to 50,000 metric tons of mineral conversion production capacity to significantly boost battery grade lithium production (counting lithium carbonate and lithium hydroxide) to meet the growing needs of the energy storage market, in particular for customers in the global transportation industry utilizing lithium ion battery technology. This expansion plan is predictable to further solidify Albemarle’s cost leadership position in the growing market for lithium carbonate and lithium hydroxide.
The new plant is predictable to come on stream in multiple phases and will source spodumene ore from Albemarle’s joint venture in Greenbushes, Australia. Albemarle has commenced feasibility studies and is evaluating potential sites, counting several locations in the United States and Asia. The plant is predictable to be operational in 2020.
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. The company’s Performance Chemicals segment offers brominated flame retardants under the Saytex brand; mineral-based flame retardants under the Martinal and Magnifin brands; and elemental bromine, alkyl bromides, inorganic bromides, brominated powdered activated carbon, and bromine fine chemicals that are used in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, paper manufacturing, water purification, beef and poultry processing, and various other industrial applications.
Shares of Veeva Systems Inc (NYSE:VEEV), dipped -0.98%, and is now trading at $26.25.
The Veeva 2015 Paperless TMF Survey: Annual CRO Report, released recently at the 7th Outsourcing in Clinical Trials New England conference, reveals a noteworthy improvement in the number of contract research organizations (CROs) using electronic trial master file (eTMF) applications from just one year ago. The global study of TMF owners found that 38% of CROs surveyed now use eTMF applications, as compared to just 21% in 2014. A number of benefits are prompting CROs’ adoption of eTMF technology. More than half (58%) say faster study start-up is a key driver, and half (50%) cite cost savings.
The industry-wide study also shows a notable shift away from paper and paper-based processes. CRO respondents are adopting electronic processes across content-intensive areas, counting clinical operations, regulatory, drug safety, and data administration. The data administration area saw the largest decrease in its use of paper, down from 27% in 2014 to 8% in 2015. Clinical operations, which manages the greatest number of TMF documents overall, also saw a sharp decline from 47% in 2014 to 34% in 2015.
Veeva Systems Inc. provides cloud-based software solutions for the life sciences industry in North America, Europe, the Asia Pacific, and Latin America. Its solutions comprise Veeva CRM, a customer relationship administration solution that allows pharmaceutical and biotechnology companies to market and sell compliantly to physicians, other healthcare professionals, and healthcare organizations through multiple touch points, counting face-to-face, email, and online; and Veeva Vault, a cloud-based content administration and partnership solution for its customers to manage content-centric processes in various departments within a life sciences company, counting clinical trials, regulatory submissions, quality administration, manufacturing, medical, sales, and marketing.
Finally, NOW Inc (NYSE:DNOW), gained 0.12% Monday.
NOW Inc. (DNOW), has planned a conference call to discuss the results for the third quarter of 2015 on Tuesday, November 3, 2015 at 8:00 am (US Central Time). Financial results for the third quarter of 2015 are predictable to be released that morning before the market opens.
NOW Inc. distributes energy and industrial products in the United States, Canada, and internationally. It offers consumable maintenance, repair, and operating supplies; and pipes, valves, fittings, flanges, electrical products, artificial lift solutions, mill tools, safety supplies, and spare parts, in addition to provides application systems and parts integration, optimization solutions, and after-sales support services.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
